Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Clinical Study of the Effect of MK-2828 on Rosuvastatin or Furosemide in Healthy People (MK-2828-005)
Sponsor: Merck Sharp & Dohme LLC
Summary
Researchers are looking for other ways to treat people who have heart failure with preserved ejection fraction (HFpEF). HFpEF is a type of heart failure where the heart becomes stiff and does not relax properly. MK-2828 is a study medicine designed to treat HFpEF. The main goal of the study is to learn if MK-2828 affects what happens to rosuvastatin or furosemide in the body.
Official title: A Two-Part Clinical Study to Evaluate the Effect of Multiple Doses of MK-2828 on Rosuvastatin (Part 1) and Furosemide (Part 2) in Healthy Participants
Key Details
Gender
All
Age Range
24 Years - 60 Years
Study Type
INTERVENTIONAL
Enrollment
39
Start Date
2026-03-18
Completion Date
2026-06-07
Last Updated
2026-03-25
Healthy Volunteers
Yes
Conditions
Interventions
Rosuvastatin
Oral administration
Furosemide
Oral administration
MK-2828
Oral administration
Locations (1)
Fortrea Clinical Research Unit Inc ( Site 0001)
Daytona Beach, Florida, United States